ATE419331T1 - L. salivarius-stamm enthaltende probiotische produkte - Google Patents

L. salivarius-stamm enthaltende probiotische produkte

Info

Publication number
ATE419331T1
ATE419331T1 AT01958512T AT01958512T ATE419331T1 AT E419331 T1 ATE419331 T1 AT E419331T1 AT 01958512 T AT01958512 T AT 01958512T AT 01958512 T AT01958512 T AT 01958512T AT E419331 T1 ATE419331 T1 AT E419331T1
Authority
AT
Austria
Prior art keywords
lactic acid
acid bacteria
probiotics
digestive tract
effective component
Prior art date
Application number
AT01958512T
Other languages
English (en)
Inventor
Azusa Kato
Seigo Nakaya
Nobuyuki Suzuki
Haruhisa Hirata
Original Assignee
Wakamoto Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd
Application granted granted Critical
Publication of ATE419331T1 publication Critical patent/ATE419331T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/179—Sakei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01958512T 2000-08-25 2001-08-27 L. salivarius-stamm enthaltende probiotische produkte ATE419331T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000254775 2000-08-25

Publications (1)

Publication Number Publication Date
ATE419331T1 true ATE419331T1 (de) 2009-01-15

Family

ID=18743660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01958512T ATE419331T1 (de) 2000-08-25 2001-08-27 L. salivarius-stamm enthaltende probiotische produkte

Country Status (9)

Country Link
US (1) US7150986B2 (de)
EP (1) EP1312667B1 (de)
JP (1) JP3944076B2 (de)
AT (1) ATE419331T1 (de)
AU (1) AU2001280178A1 (de)
DE (1) DE60137235D1 (de)
ES (1) ES2316463T3 (de)
SI (1) SI1312667T1 (de)
WO (1) WO2002016554A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
KR100843020B1 (ko) * 2002-03-29 2008-07-01 가부시키가이샤 프렌테 인터내셔날 유산균을 유효성분으로 하는 생균제제 및 유산균 함유 식품
JP4212838B2 (ja) 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
JP2005013211A (ja) * 2002-09-27 2005-01-20 Wakamoto Pharmaceut Co Ltd 乳酸菌含有食品組成物
US7179460B2 (en) * 2002-12-05 2007-02-20 Danisco A/S Bacterial composition and its use
US20050281756A1 (en) * 2004-06-14 2005-12-22 Eamonn Connolly Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
US20040197304A1 (en) 2003-04-01 2004-10-07 The Procter & Gamble Company And Alimentary Health, Ltd. Methods of determining efficacy of treatments of inflammatory diseases of the bowel
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US7256202B2 (en) * 2003-12-31 2007-08-14 Halow George M Composition and method for treatment of hepatic encephalopathy
FR2869622B1 (fr) * 2004-04-28 2008-04-18 Rhodia Chimie Sa Comprimes de micro-organismes pour ensemencement direct
EP1634948A1 (de) 2004-09-10 2006-03-15 Basf Aktiengesellschaft Mittel und Verfahren zur Vorbeugung und/oder Behandlung von Karies
EP2261323A1 (de) 2005-05-31 2010-12-15 The Iams Company Probiotische Katzen-Laktobazillen
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
WO2008074473A2 (en) * 2006-12-19 2008-06-26 Basf Se Uses and methods for preventing and/or treating caries caused by mutants streptococci
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
US20080299098A1 (en) * 2007-04-24 2008-12-04 Chea-Yun Se Broad-Spectrum Antibacterial and Antifungal Activity of Lactobacillus Johnsonii D115
PL210465B1 (pl) * 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2133414A1 (de) 2008-06-11 2009-12-16 Basf Se Anwendungen und Verfahren zur Vorbeugung und/oder Behandlung von Mundgeruch
DK2455095T3 (en) 2009-07-16 2017-07-24 Univ Hiroshima PROPHYLACTIC, IMPROVING OR THERAPEUTIC AGENT FOR ORAL DISEASES
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2485744A4 (de) * 2009-10-09 2014-01-22 Prothera Inc Zusammensetzungen und verfahren mit pediokokken zur reduzierung mindestens eines symptoms für autismusspektrumserkrankungen bei einem patienten mit diagnostizierter autismusspektrumserkrankung
TWI384990B (zh) * 2010-01-15 2013-02-11 Glact Biotech Co Ltd 用於治療胃潰瘍之乳酸菌菌株之食品組成物以及醫藥組成物
JP2012092094A (ja) * 2010-09-30 2012-05-17 Wakamoto Pharmaceutical Co Ltd 油脂中に乳酸菌を含有する口腔用組成物
KR101062555B1 (ko) * 2011-01-11 2011-09-06 광주시농업기술센터 축산용 생균제 조성물 및 그 제조방법
US9856451B2 (en) 2011-12-28 2018-01-02 Yamada Bee Company Inc. Lactic acid bacterium having IgA production promoting activity, and use thereof
KR101381794B1 (ko) * 2012-04-10 2014-04-07 씨제이제일제당 (주) 타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물
FR2999601B1 (fr) * 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
EA034376B1 (ru) 2013-07-05 2020-01-31 Интегра Медикал Инк. Композиции для оздоровления полости рта
TWI581791B (zh) * 2013-10-01 2017-05-11 行政院國軍退除役官兵輔導委員會高雄榮民總醫院 六羥季銨鹽類治療哺乳動物腸病毒７１型腦炎的用途
TWI577380B (zh) * 2015-01-14 2017-04-11 Lactic acid bacteria composition for the treatment of gastrointestinal disorders
JP6236052B2 (ja) * 2015-11-16 2017-11-22 欽也 斉藤 口内虫歯予防粉及び口内虫歯予防粉の製造方法
JP6190512B1 (ja) * 2016-10-27 2017-08-30 肇 福永 Ｍ細胞を制御する乳酸菌の生成方法
PT3517119T (pt) 2018-01-26 2021-11-30 Probisearch S L U Composição compreendendo nova estirpe de lactobacillus salivarius e método para a prevenção e tratamento de otite e infeções respiratórias superiores
CN109486700A (zh) * 2018-08-31 2019-03-19 石家庄君乐宝乳业有限公司 副干酪乳杆菌n1115预防结肠炎的应用及相应的益生菌粉、应用
KR102251294B1 (ko) * 2018-11-06 2021-05-12 주식회사 메디뉴트롤 락토바실러스 살리바리우스 v133 균주의 사균체를 유효성분으로 함유하는 알코올성 위염의 예방, 개선 또는 치료용 조성물
CN110923172B (zh) * 2019-12-25 2023-05-09 江西仁仁健康微生态科技有限公司 一株具有通便功效和降胆固醇功效的唾液乳杆菌及应用
CN115466699B (zh) * 2022-09-28 2023-03-31 成都大熊猫繁育研究基地 熊猫源唾液乳杆菌及在治疗或预防炎症性肠病中的应用
CN115725456B (zh) * 2022-10-11 2024-06-21 四川大学 一种唾液乳杆菌及其应用
CN119074775A (zh) * 2023-06-06 2024-12-06 四川厌氧生物科技有限责任公司 一种防治抗肿瘤治疗相关性腹泻的益生菌组合物及其应用
CN117229975A (zh) * 2023-10-23 2023-12-15 塔里木大学 一种新型唾液乳酸杆菌lzzay01及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3581091D1 (de) * 1984-03-09 1991-02-07 Advance Kk Anti-karies- oder anti-periodontitismittel.
JP4021951B2 (ja) * 1996-03-01 2007-12-12 わかもと製薬株式会社 乳酸菌を有効成分とする抗胃炎剤、抗潰瘍剤および醗酵食品
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
PT956858E (pt) * 1998-04-30 2002-04-29 Renata Maria Anna Caval Vesely Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
CA2354054C (en) * 1998-12-11 2011-04-12 Urex Biotech, Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
JP4603116B2 (ja) * 1999-12-02 2010-12-22 わかもと製薬株式会社 乳酸菌含有組成物、医薬及び食品

Also Published As

Publication number Publication date
JP3944076B2 (ja) 2007-07-11
EP1312667A1 (de) 2003-05-21
AU2001280178A1 (en) 2002-03-04
EP1312667A4 (de) 2005-01-19
WO2002016554A9 (en) 2002-03-28
US20030157079A1 (en) 2003-08-21
ES2316463T3 (es) 2009-04-16
DE60137235D1 (de) 2009-02-12
US7150986B2 (en) 2006-12-19
EP1312667B1 (de) 2008-12-31
WO2002016554A1 (en) 2002-02-28
SI1312667T1 (sl) 2009-04-30

Similar Documents

Publication Publication Date Title
DE60137235D1 (de) L. salivarius-Stamm enthaltende probiotische Produkte
ATE407687T1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
KR101255894B1 (ko) 락토바실러스 플란타룸 및 그의 용도
HUP0100428A2 (hu) Lactobacillus paracasei subsp. paracasei fajhoz tartozó baktériumtörzs, abból élelmiszeripari alkalmazás céljára előállított készítmények, valamint a baktériumtörzset tartalmazó termékek
SE0402406L (sv) Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
ATE323503T1 (de) Bacillus coagulans-zusammensetzung und deren verwendung
WO2001058465A3 (en) Probiotic therapy for newborns
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
BR0315209A (pt) Formulações nutritivas que contêm substâncias simbióticas
AU5113798A (en) Lactic ferment comprising a particular strain of (lactobacillus acidophilus) and use thereof
WO2000007606A3 (en) Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
Etebarian et al. Oral Lactobacillus species and their probiotic capabilities in patients with periodontitis and periodontally healthy individuals
Koll et al. Screening and evaluation of human intestinal lactobacilli for the development of novel gastrointestinal probiotics
EP0861905A3 (de) Neuartige Lactobacillusstämme verwendbar zur Behandlung von Störugen des Magendarmsystems
DE69622855D1 (de) Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
EP1611796A4 (de) Futtermittelzusammensetzung
WO2003053474A3 (en) Use of micro-organisms for a directed delivery of substances to specific parts of the gut
MY140870A (en) Nutrition supplement containing lactobacillus acidophilus, yeast and soy protein
CA2314775A1 (en) Novel lactic acid bacterial preparation that reduces triglycerides and cholesterol
DE60012521D1 (de) BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD
Singroha et al. Isolation and characterization of potential probiotic Lactobacillus gasseri strains isolated from different sources
WO2000067583A3 (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
Cho et al. In vitro growth-inhibiting effects of leaf extracts from Pinus species on human intestinal bacteria
Brankova et al. Interaction between lactic acid bacteria and some harmful organisms, depending on their amount in the medium
Guaglianone et al. Sex Pheromone Response, Clumping, and

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties